Home > About us

About us

Major mental disorders such as schizophrenia, affective disorders, and developmental disorders are severe disorders showing high prevalence rate in every population. They not only bring long-lasting suffering to patients and their families, but also cause tremendous loss from an economical view. Surprisingly, cause of illness and pathophyshiology of mental disorders remain largely unclear. The Department of Molecular Psychiatry has been established at the Graduate School of Medicine, University of Tokyo from February 2010 to January 2013, by the donation from Astellas Pharma, Dainippon Sumitomo Pharma, and Yoshitomi Yakuhin, and from February 2013, by the donation from Dainippon Sumitomo Pharma, and Yoshitomi Yakuhin. The aim of this department is to contribute the understanding of cause of illness and pathophysiology of major mental disorders at the molecular level, through the close collaboration with Department of Neuropsychiatry at the University of Tokyo.